Men Get Unneeded Prostate Cancer Diagnoses
They said as many as 29 percent of white men and 44 percent of blacks diagnosed using the PSA test would die of something other than prostate cancer even if they were never treated for it. Some may be getting surgery, chemotherapy or radiation therapy they do not need, the study suggested.
The findings, sure to be controversial in a society where men are often reluctant to be screened for cancer anyway, suggest doctors should be careful when discussing a prostate cancer diagnosis with patients.
The prostate specific antigen or PSA test was approved in 1986 by the U.S. Food and Drug Administration. It measures levels of a molecule produced only by prostate cells, and overproduced by prostate cancer cells.
The higher the levels, the more likely a man is to have prostate cancer. Prostate cancer is the second leading cancer killer of men, after lung cancer, affecting 189,000 men this year in the United States and killing 30,000.
The test doubled the number of men diagnosed with the disease.
"Between 1986 and 1992, the overall age-adjusted incidence rate for prostate cancer increased by over 100 percent, from 86 to 179 per 100,000 per year," the researchers wrote in their report, published in the **** Journal of the National Cancer Institute****.
There is no doubt the test has saved lives, as prostate cancer is easy to treat when caught at early stages.
But it can be a very slow-growing disease, and many men are found to have had prostate cancer after they die of something else -- often heart disease, the No. 1 killer of both men and women in the industrialized world.
----- Treatment Can Mean Impotence or Incontinence -------- As treatment often involves surgery that can leave a man impotent or incontinent, doctors and patients are both keen to be careful about what a diagnosis of cancer means.
Ruth Etzioni of the Fred Hutchinson Cancer Research Center in Seattle and colleagues used a computer simulation of 2 million hypothetical men aged between 60 and 84.
They compared what their model predicted would have been the prostate cancer rate between 1988 and 1998 if there was no PSA test, with what was actually registered in the National Cancer Institute's surveillance, epidemiology and end results database.
They found about 29 percent of white men diagnosed with prostate cancer, and 44 percent of black men, would not have ever been diagnosed in the days before PSA testing. This suggests they had such a slow-growing form of cancer that it would never have caused significant symptoms.
The same researchers found in 1998 that only 9 percent of all American men were ever diagnosed with prostate cancer before 1986. Autopsy evidence has shown that 36 percent of white men and 28 percent of black men turn out to have had prostate cancer when they get an autopsy after dying of something else.
Based on this, the researchers said, only 4 percent of white men and 7 percent of all black men in the population will be diagnosed with cancer using a PSA test and thus over-diagnosed -- an argument that suggests most men do not risk getting an "over-diagnosis" of prostate cancer.
"Screening, for any disease, is often mired in controversy," Reuters quoted Dr. Siu-Long Yao of Merck Research Laboratories and Grace Lu-Yao of Healthstat in Princeton, New Jersey, as writing in an editorial in the journal.
When speaking to his doctor, every man who gets a PSA screening test needs to consider the possibility that even if diagnosed with cancer, he may not need immediate treatment for it, they wrote..